Eli Lilly

Lilly is carving up to $1B out of its struggling R&D division
Fierce Biotech
Tue, 01/7/14 - 06:55 pm
Eli Lilly
R&D
Lilly issues 2014 forecast in line with Wall St estimates
Yahoo/Reuters
Tue, 01/7/14 - 09:27 am
Eli Lilly
Grading Pharma In 2013: 16 Drug Companies Ranked
Forbes
Tue, 12/31/13 - 10:17 am
Bristol-Myers Squibb
Celgene
Gilead Sciences
Biogen Idec
AbbVie
Roche
JNJ
GSK
Amgen
Novo Nordisk
Pfizer
Novartis
Merck
Sanofi
AstraZeneca
Eli Lilly
Big Pharma Stocks: Year in Review
Yahoo/TheStreet.com
Tue, 12/24/13 - 09:50 am
Big Pharma
drug stocks
Merck
JNJ
GSK
Eli Lilly
Pfizer
Sanofi
Bristol-Myers Squibb
Diabetes Programs Now Crucial For Eli Lilly
Seeking Alpha
Mon, 12/23/13 - 10:24 am
diabetes
Eli Lilly
Novo Nordisk
Teva
Cymbalta
generics
Pfizer's Expiring Viagra Patent Adversely Affects Other Drugmakers Too
Forbes
Sat, 12/21/13 - 11:45 am
Pfizer
Viagra
Eli Lilly
erectile dysfunction
Bayer
Levitra
Cialis
[video]The Biggest Victims of the Patent Cliff in 2014
Motley Fool
Mon, 12/16/13 - 08:11 am
patents
AstraZeneca
Eli Lilly
Cymbalta
Nexium
Evaluating Lilly's Dividend Prospects In Light Of Cymbalta Patent Expiration
Seeking Alpha
Sat, 12/14/13 - 12:41 pm
Eli Lilly
FDA approves 6 low-cost versions of blockbuster antidepressant pill Cymbalta
Yahoo/AP
Thu, 12/12/13 - 07:16 am
FDA
patents
antidepressants
Cymbalta
Eli Lilly
FDA to phase out some antibiotic use in animal production
Reuters
Wed, 12/11/13 - 11:45 am
FDA
antibiotics
animal health
Zoetis
Eli Lilly
Eli Lilly: Fasten Your Seat Belts for a Bumpy Ride
Motley Fool
Wed, 12/11/13 - 08:46 am
Eli Lilly
antidepressants
Cymbalta
patents
generics
Lilly depression drug fails late-stage trial
Yahoo/Reuters
Thu, 12/5/13 - 08:31 am
Eli Lilly
edivoxetine
major depressive disorder
norepinephrine reuptake inhibitors
5 Blockbuster Drugs Going Off Patent in 2014
Motley Fool
Wed, 12/4/13 - 08:38 am
patents
Eli Lilly
Evista
Teva
Copaxone
Novartis
Exforge
Sandostatin LAR
Nexium
AstraZeneca
2014 FDA Drug Approval Decision Calendar
TheStreet.com
Wed, 11/27/13 - 08:39 am
FDA
drug approvals
GSK
Gilead
Theravance
Auxilium
Amarin
Bristol-Myers Squibb
Biogen Idec
Pozen
Vanda
Chelsea Therapeutics
pSivida
Alimera
United Therapeutics
Biomarin
JNJ
Pharmacyclics
Celgene
MannKind
Santarus
AstraZeneca
Durata Therapeutics
Eli Lilly
Omeros
BioDelivery Sciences
Anacor
Keryx
Cubist Pharmaceuticals
Nektar
New Research And Competition Could Hurt AbbVie's Other Blockbuster
Seeking Alpha
Thu, 11/21/13 - 02:05 pm
AbbVie
Auxilium
GSK
Eli Lilly
Androgel
Alzheimer's Disease Could Become the Next Frontier in Pharmaceutical Research
Motley Fool
Tue, 11/19/13 - 07:40 am
Alzheimer's disease
R&D
JNJ
Eli Lilly
Pfizer
Elan
General Electric
Vizamyl
Amyvid
bapineuzumab
solanezumab
Eli Lilly to invest $700M to enhance global insulin manufacturing capacity
Yahoo/Fly on the Wall
Thu, 11/14/13 - 10:29 am
Eli Lilly
drug manufacturing
insulin
diabetes
Pfizer, Lilly Vs. Rivals In Potential Pain Drug Rivalry
Seeking Alpha
Wed, 11/13/13 - 08:32 am
Pfizer
Eli Lilly
painkillers
tanezumab
Eli Lilly’s Lackluster Pipeline + Premium Valuation = Goldman Sachs Downgrade
Barron's
Mon, 11/11/13 - 02:19 pm
Eli Lilly
Eli Lilly Goes Down The Hill As Patents Expire
Seeking Alpha
Sat, 11/9/13 - 12:33 pm
Eli Lilly
patents

Pages